Condition: Coronary Arterial Disease (CAD) · Sponsor: Amplitude Vascular Systems, Inc.
A prospective, open-label, multi-site, FIH with up to fifteen (n=15) patients to assess the safety and preliminary effectiveness of the AVS Pulse Intravascular Lithotripsy™ System (Pulse IVL™ System) when used for the treatment of coronary artery disease.
This description comes directly from the study's public registry record.
Elizabeth Galle · 651-324-4790 · liz.galle@avspulse.com
Elise Gendreau · elise.gendreau@avspulse.com
Always discuss trial participation with your own doctor first.
| Monash Health, Victorian Heart Hospital | Melbourne, Victoria, Australia | Recruiting |
| Auckland City Hospital | Auckland, New Zealand | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07510438